Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco Labs" or "the Company"), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the opening of a new Sunnyside dispensary located at 3900 N 9 th Ave. in Pensacola, FL. Sunnyside Pensacola is the Company's second store in the Panhandle region. With today's opening, Cresco Labs operates 12 Florida stores and 44 nationwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207005308/en/
Cresco Labs' new Pensacola dispensary is its second in Florida's Panhandle and 44th nationwide. (Photo: Business Wire)
"This is our fourth Florida new store opening since the closing of the Bluma Wellness acquisition, and we're on target to double our store count in the state by the anniversary date," said Charlie Bachtell, CEO and Co-founder of Cresco Labs. "We're going deeper and expanding accessibility to our branded products in the two biggest medical markets, Florida and Pennsylvania. We're already the top seller of branded cannabis in Pennsylvania, and we're excited to expand access to those same amazing products to patients throughout Florida."
Sunnyside Pensacola is centrally located in the city near Cordova Mall, across the bridge from Pensacola Beach and the suburb of Gulf Breeze, and a few blocks away from Interstate 110—offering broad accessibility to daily commuters and residents.
The store will serve patients with a medical card issued by the state of Florida. Patients can place orders online through the Sunnyside.shop website or utilize next-day delivery. Orders can also be placed both in-store or via phone at 877-395-1009. Regular store hours are Monday through Saturday, 10AM to 8PM, and Sunday, 10AM to 5PM.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods ("CPG") approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs' national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry's largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com .
Forward Looking Statements
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,' ‘will,' ‘should,' ‘could,' ‘would,' ‘expects,' ‘plans,' ‘anticipates,' ‘believes,' ‘estimates,' ‘projects,' ‘predicts,' ‘potential' or ‘continue' or the negative of those forms or other comparable terms. The Company's forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under "Risk Factors" in the Company's Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company's forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs' shares, nor as to the Company's financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company's forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
Jason Erkes, Cresco Labs
Chief Communications Officer
For general Cresco Labs inquiries: